• empty
    No Content
  • 25 TodayImportanceALL
    • 03:07

      Celldex Therapeutics Inc :Celldex Therapeutics Presents Positive 12 Week Results From Barzolvolimab Phase 2 Study In Chronic Spontaneous Urticaria.52 Week Results And Phase 3 Csu Trial Initiations Anticipated In 2024.Barzolvolimab Was Well Tolerated With A Favorable Safety Profile..Celldex Therapeutics- Primary & Secondary Endpoints Met With Clinically Meaningful And Statistically Significant Decreases In Urticaria Disease Activity.

      01:09

      Moncler SpA :Hereby Informs That Grinta S.R.L. (A Corporate Vehicle Of Rivetti Family) Has Notified Its Withdrawal From Double R.Double R Will Assign To Grinta A Number Of Moncler'S Ordinary Shares.Grinta Holds A Quota Representing Approx. 16.473% Of Double R Corporate Capital.Rivetti Family Will, Therefore, Hold Through Grinta Its Investment In Moncler Shares.Double R Holds, In Turn, Approx. 23.721% Of Share Capital Of Moncler S.P.A..Carlo Rivetti Will Continue To Collaborate With Moncler As Member Of Board Of Directors Of As Well As Chairman Of Board Of Stone Island..

    • 21:47

      Berkshire Hathaway Inc BRKA.N:– Q4 Net Earnings Attributable To Berkshire Shareholders $37.57 Billion Versus Year-Earlier $18.08 Billion.– Q4 Operating Earnings $8.48 Billion Versus Year-Earlier $6.62 Billion.– Q4 Net Earnings Per Average Equivalent Class A Share $26,043.– Q4 Net Gain From Investments And Derivatives $29.09 Billion Versus Year-Earlier $11.46 Billion Gain.– Insurance Float Was Approximately $169 Billion As Of Dec 31.– Fy Net Earnings Attributable To Berkshire Shareholders $96.22 Billion Versus Year-Earlier $22.75 Billion Net Loss.– Fy Operating Earnings $37.35 Billion Versus Year-Earlier $30.85 Billion.Q4 Earnings Per Share View $5470.79 -- Lseg Ibes Data.– Approximately $2.2 Billion Was Used To Repurchase Berkshire Shares During The Fourth Quarter Of 2023.– Berkshire Says Approximately $9.2 Billion Was Used To Repurchase Berkshire Shares In 2023.– Berkshire Says It Had 1.4 Million Class A Equivalent Shares Outstanding As Of Dec 31.Berkshire Hathaway – Foreign Currency Exchange Losses Related To Non-U.S. Dollar Denominated Debt Of Approximately $684 Million In The Fourth Quarter.Berkshire Hathaway – 79% Of Aggregate Fair Value Of Its Equity Investments Was Concentrated In Amex, Apple, Bofa, Coca-Cola And Chevron Of Dec 31.Berkshire Hathaway – On January 31, 2023, Acquired An Additional 41.4% Interest In Pilot Travel Centers, Llc For Approximately $8.2 Billion.

      21:39

      Feb 24 (Reuters) - :Next Has Approached Administrators To The Body Shop About A Potential Deal To Purchase Parts Of The Cosmetics Chain - Sky News.

      21:00

      Berkshire Hathaway 4Q Net $37.57B >BRKA

      21:00

      Berkshire Hathaway 4Q Railroad Operating Earnings $1.36B >BRKA

      21:00

      Berkshire Hathaway 4Q Insurance-Underwriting Operating Earnings $848M >BRKA

      21:00

      Berkshire Hathaway 4Q EPS $26043.00 >BRKA

      21:00

      Berkshire Hathaway 4Q Insurance-Investment Income Operating Earnings $2.76B >BRKA

      21:00

      Berkshire Hathaway 4Q Utilities and Energy Operating Earnings $632M >BRKA

      21:00

      Berkshire Hathaway 4Q Investment, Derivative Gains $29.09B >BRKA

      21:00

      Berkshire Hathaway 4Q Operating Earnings $8.48B >BRKA

      21:00

      Berkshire Hathaway 4Q Other Operating Loss $804M >BRKA

      18:19

      Feb 24 (Reuters) - :Japan'S Welcia Holdings, Tsuruha Holdings Considering Integration - Nikkei.Welcia Parent Aeon Making Final Arrangements To Buy Oasis Management'S Stake In Tsuruha - Nikkei.Further Company Coverage: 3391.T.

      09:17

      Alvotech SA :Reg-Alvotech And Teva Announce U.S. Approval Of Simlandi® (Adalimumab-Ryvk) Injection, The First Interchangeable High-Concentration, Citrate-Free Biosimilar To Humira®.Simlandi Will Qualify For Interchangeable Exclusivity In U.S. For Some Concentration Strengths.Both Alvotech And Teva Expect To Launch Simlandi In U.S. Imminently With Interchangeability Designation..Simlandi Can Be Substituted For Humira At Pharmacy Level, Subject To State Pharmacy Laws..

 
 
 
 

Most Discussed

 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial